Viewing nowDongkwang Rosuvastatin Calcium Tablets 10mg
Rosuvastatin Calcium 10.4mg
Tablet · Prescription medication
Dongkwang Pharmaceutical Co., Ltd.

MFDS item code 201400371 · Approved 2014.01.28 · Insurance code 645905560
Improvement of dyslipidemia, inhibition of the progression of atherosclerosis, and prevention of cardiovascular disease
This medication is used as an adjunct when dietary and exercise interventions alone are inadequate for patients with various forms of hypercholesterolemia and hyperlipidemia. It is particularly effective for patients with primary hypercholesterolemia, heterozygous familial hypercholesterolemia, and mixed hyperlipidemia. Additionally, it helps lower cholesterol levels in patients with homozygous familial hypercholesterolemia when used alongside dietary and other lipid-lowering therapies. This medication plays a role in delaying the progression of atherosclerosis by lowering total cholesterol and LDL-cholesterol levels to target levels. It is also applicable to pediatric patients aged 10 to 17 years with familial hypercholesterolemia, aiding in cholesterol control based on risk factors. Moreover, it helps reduce the risk of stroke, myocardial infarction, and arterial revascularization in adult patients at high cardiovascular disease risk. Thus, this medication is used to improve various conditions associated with hypercholesterolemia.
1. Primary hypercholesterolemia (type IIa, including heterozygous familial hypercholesterolemia), mixed dyslipidemia (type IIb), primary dysbetalipoproteinemia (type III), and homozygous familial hypercholesterolemia Patients should follow a standard cholesterol-lowering diet before and during treatment with this medicine, and continue it throughout the treatment period. This medicine may be taken at any time of day, with or without food. The initial dose is 5 milligrams once daily. If a greater reduction in LDL cholesterol is required, the dose may be adjusted to the maintenance dose. The maintenance dose is 10 milligrams once daily, which is adequate for most patients. The maintenance dose should be adjusted appropriately at intervals of 4 weeks or longer according to LDL cholesterol levels, treatment goals, and patient response; it may be increased to a maximum of 20 milligrams per day. 3. Elderly patients: No dosage adjustment is necessary. 4. Patients with renal impairment: No dosage adjustment is necessary in patients with mild or moderate renal impairment. Do not administer to patients with severe renal impairment. Exercise particular caution when administering this medicine at 20mg to patients with moderate renal impairment. 5. Patients with hepatic impairment: No increase in systemic exposure to rosuvastatin was observed in patients with a Child-Pugh score of 7 or less, but an increase was observed in patients with a Child-Pugh score of 8 or 9. Renal function testing should be considered in these patients. There is no experience with administration in patients with a Child-Pugh score greater than 9. Do not administer this medicine to patients with active liver disease. 6. Race: Because systemic exposure to this medicine is increased in Asian patients, the recommended initial dose is 5 milligrams. Administration of the 40-milligram dose is contraindicated. 7. Patients predisposed to myopathy: The recommended initial dose for patients predisposed to myopathy is 5 milligrams. Administration of the 40-milligram dose is contraindicated in some of these patients.
Age 10 to 17 years: The usual dose range is 5 milligrams to 20 milligrams once daily. (There are no clinical data on doses greater than 20 milligrams in pediatric patients.) The dose should be adjusted individually according to the recommended treatment goal for each patient. The dose should be adjusted at intervals of 4 weeks or longer. Children under 10 years: Safety and efficacy have not been established.
This medication should not be used in certain patients. For example, patients with allergies to the components of this medication, those with severe liver dysfunction, patients with muscle disorders, and women who are pregnant or nursing should not take this medication. Additionally, patients with significantly impaired kidney function should also avoid this medication for safety. This medication may affect liver function; therefore, patients with liver disease or those who consume alcohol heavily should undergo liver function tests before taking it and should regularly monitor liver status during treatment. If symptoms such as muscle pain or muscle weakness occur, the healthcare provider should be notified immediately, and if severe muscle damage is suspected, the medication should be discontinued. Since this medication contains lactose, caution is advised for patients with lactose intolerance. Furthermore, as there may be drug interactions, patients taking other medications should consult with a doctor or pharmacist. Women of childbearing potential should practice appropriate contraception while taking this medication and discontinue it immediately if they become pregnant. It is important to regularly check liver function and muscle status during the course of this medication and to promptly inform healthcare providers of any adverse symptoms.
Hypersensitivity reactions including angioedema, diabetes, headache, dizziness, constipation, nausea, abdominal pain, pancreatitis, itching, rash, urticaria, myalgia, myopathy, rhabdomyolysis, weakness, polyneuropathy, amnesia, peripheral neuropathy, myasthenia gravis, cough, dyspnea, diarrhea, ocular myasthenia gravis, thrombocytopenia, jaundice, hepatitis, transaminase elevation, Stevens-Johnson syndrome, drug reaction with eosinophilia and systemic symptoms, lichenoid drug rash, lupus-like syndrome, muscle rupture, arthralgia, immune-mediated necrotizing myopathy, hematuria, edema, depression, sleep disorders, interstitial lung disease, sexual dysfunction, gynecomastia, fatal and non-fatal liver failure, cognitive impairment, ALT elevation, chest pain, muscle cramps, fatigue, numbness, paresthesia, chest discomfort, anorexia, abdominal distension, abnormal liver function tests, syncope, myalgia, gout, erectile dysfunction, acute renal failure, oligoanuria, elevated serum creatinine
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly sealed container to avoid exposure to air or moisture. The appropriate storage temperature is between 1 degree and 30 degrees Celsius at room temperature, and it is advisable to avoid excessively hot or cold places.
Pink round film-coated tablet
30 tablets/bottle, 100 tablets/bottle, 300 tablets/bottle, 30 tablets/box [(10 tablets/PTP) × 3]
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowRosuvastatin Calcium 10.4mg
Tablet · Prescription medication
Dongkwang Pharmaceutical Co., Ltd.

Rosuvastatin Calcium 10.4mg
Tablet · Prescription medication
AstraZeneca Korea Co., Ltd.

Rosuvastatin Calcium 20.8mg
Tablet · Prescription medication
AstraZeneca Korea Co., Ltd.

Rosuvastatin Calcium 5.2mg
Tablet · Prescription medication
AstraZeneca Korea Co., Ltd.

Rosuvastatin Calcium 10.4mg
Tablet · Prescription medication
Chong Kun Dang Pharmaceutical Corp.

Rosuvastatin Calcium 10.4mg
Tablet · Prescription medication
Dong Gu Bio Pharmaceutical Co., Ltd.

Rosuvastatin Calcium 10.4mg
Tablet · Prescription medication
Boryung Pharmaceutical Co., Ltd.

Rosuvastatin Calcium 20.8mg
Tablet · Prescription medication
Jongkundang Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.